Breadcrumb

A clear picture of the cost and efficacy of COVID-19 outpatient treatments

In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...

Unraveling the complexity of vitamin B12 diseases

Nature Communications study has implications for treatment of patients and genetic counselling

A new understanding of mental illness

Three key factors might offer 90% accuracy in predicting wide range of psychiatric disorders

Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity

Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...

Dr. Tarek Hijal appointed Chair of the National Radiation Oncology Committee

The MUHC is proud and pleased to announce that the Programme québécois de cancérologie (PQC) of...

MUHC ranks in the top 3 on the list of Canada's Top 40 Research Hospitals

Thanks to RI-MUHC researchers, trainees and staff for their continued commitment to excellence

RI-MUHC researchers led one of Québec Science magazine’s top 10 discoveries of the year

Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer

Diversifying the next generations

Loydie Jerome-Majewska does more than study how errors occur in early embryo development, in order to prevent them